Connie Wheat
Family · San Antonio, TXNPI 1497265821
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations.
Across 178 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$412
- Lilly USA, LLC$331
- Corium, LLC$289
- AstraZeneca$204
- Sobi, Inc$184
- Novo Nordisk$176
- plus $2K from 36 others
What the payments were for
- Food & beverage$3,38597%
- Education$903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $412 |
| Lilly USA, LLC | 17 | $331 |
| Corium, LLC | 16 | $289 |
| AstraZeneca(2 entities) | 9 | $204 |
| Sobi, Inc | 6 | $184 |
| Novo Nordisk | 10 | $176 |
| Sanofi Pasteur Inc. | 7 | $163 |
| Pfizer | 7 | $139 |
| AbbVie | 6 | $117 |
| Amarin Pharma, Inc. | 7 | $116 |
| Merck | 7 | $102 |
| Regeneron Healthcare Solutions, Inc. | 2 | $93 |
| Johnson & Johnson | 4 | $93 |
| Alk-abello, Inc | 3 | $91 |
| Genmab U.S., Inc. | 1 | $90 |
| Supernus Pharmaceuticals, Inc. | 5 | $87 |
| AVEO Pharmaceuticals, Inc. | 3 | $72 |
| Si-bone, Inc. | 1 | $60 |
| Springworks Therapeutics, Inc. | 1 | $56 |
| Daiichi Sankyo Inc. | 3 | $51 |
| Ironshore Pharmaceuticals Inc. | 3 | $49 |
| Cranial Technologies, Inc | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Bristol Myers Squibb | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Tris Pharma Inc | 2 | $37 |
| Pharmaand GmbH | 3 | $30 |
| Incyte Corporation | 1 | $28 |
| Amgen | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Radius Health, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $20 |
| Novartis | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Gilead | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Organon | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $11 |
| Genentech USA, Inc. | 1 | $8 |
How this compares
$3,475 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 59 | $677 |
| Losartan Potassium | 18 | $306 |
| Rosuvastatin Calcium | 11 | $195 |
| Pravastatin Sodium | 13 | $193 |
| Atorvastatin Calcium | 24 | $184 |
| Lisinopril | 26 | $181 |
| Citalopram HbrCitalopram Hydrobromide | 20 | $153 |
| Hydrochlorothiazide | 18 | $140 |
| Omeprazole | 16 | $136 |
| Gabapentin | 13 | $81 |
| Azithromycin | 11 | $64 |
| Metformin Hcl ErMetformin Hcl | 11 | $59 |
| Metformin Hcl | 18 | $39 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Febbie PhiriSan Antonio$31K
- Annette GantzSan Antonio$31K
- Renee ChisumSan Antonio$28K
- Thimios PartalasSan Antonio$27K
- David WeirDallas$959K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.